OR WAIT null SECS
© 2023 MJH Life Sciences and Opthalmology Times Europe. All rights reserved.
© 2023 MJH Life Sciences™ and Opthalmology Times Europe. All rights reserved.
Global experts who manage patients with retinal disorders comment on current treatment barriers and highlight newer therapies and delivery systems coming to market.
June 30th 2021
A panel of global experts who treat patients with retinal diseases suggest causes of age-related macular degeneration, diabetic macular edema, and inherited retinal disease.
Types of tests and criteria that can be used to diagnose conditions such as age-related macular degeneration, diabetic macular edema, and inherited retinal disease.
July 12th 2021
An overview of the current treatment landscape for age-related macular degeneration and factors that impact treatment selection.
A discussion regarding the roles of various treatments available for diabetic macular edema and considerations for selecting and sequencing therapy.
July 19th 2021
Dr Mariya Moosajee highlights therapies approved as well as under study to improve treatment for patients with inherited retinal disease.
Drawbacks and challenges associated with the administration of anti-VEGF injections currently available to treat retinal diseases.
July 26th 2021
Challenges associated with delivering therapies currently available to treat retinal disorders and methods being explored to improve drug delivery to patients.
Following a discussion regarding drug delivery challenges in retinal disease, a panel of global experts suggest what types of technological requirements and improvements they would like to see occur in the field.
August 2nd 2021
Types of delivery methods currently being explored to improve treatment for patients with retinal disorders.
August 4th 2021
Ophthalmologists highlight recent treatment advances in diabetic macular edema and wet age-related macular degeneration.